#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypertriglyceridaemia Peripheral primitive neuroectodermal tumour of soft tissue Acquired haemophilia Factor VIII deficiency Pulmonary fibrosis Pyoderma gangrenosum Liposarcoma Spinal muscular atrophy Rett syndrome Alveolar rhabdomyosarcoma Staphylococcal infection Squamous cell carcinoma of the oral cavity Interstitial lung disease T-cell type acute leukaemia Blood iron increased More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Life with Disease Mucous membrane pemphigoid Chondrosarcoma metastatic – Basic Information Mucopolysaccharidosis II – Treatment Langerhans cell sarcoma – Trials in Disease Pemphigus Leiomyosarcoma metastatic – Life with Disease Pulmonary fibrosis – Life with Disease Haemolytic uraemic syndrome – Treatment Basal cell naevus syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cemiplimab Relugolix Atuliflapon Emactuzumab IMB 101 Levamisole Hydrochloride Tropicamide Dordaviprone Foscarnet Daridorexant Ceritinib Pemigatinib ROC-101 HYDROCHLORIDE Verapamil Hydrochloride Magnesium Hydroxide GS-248 Vemircopan Danazol Zanubrutinib Alnuctamab More therapies…

    Learn about Your Condition

    Pancreatic carcinoma Underweight Epileptic encephalopathy Breast proliferative changes Essential hypertension Fallopian tube cancer stage IV Type 1 diabetes mellitus Metastasis Glomerulonephritis membranous Thrombolysis Gouty arthritis Dementia Gestational diabetes Bile duct cancer Ocular lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Regionshospitalet Viborg

Regionshospitalet Viborg

Heibergs Alle 4, Viborg, 8800, Denmark

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Reducing Cardiovascular Disease in Type 1 Diabetes Patients Using Finerenone and Semaglutide

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Finerenone
    • Semaglutide
    • Sotagliflozin
    Denmark

  • Study on the Effects of Bisoprolol and Verapamil in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Bisoprolol Fumarate
    • Hydrochlorothiazide
    • Verapamil
    Denmark

  • Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Haemodialysis
    • Peritoneal dialysis
    Investigated Drugs:
    • Warfarin Sodium
    Denmark

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    Denmark Finland Norway Sweden

  • A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

    Not recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Rimegepant
    Austria Belgium Denmark Finland France Germany +4

  • Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary progressive multiple sclerosis
    • Relapsing-remitting multiple sclerosis
    • Secondary progressive multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    • Rituximab
    Denmark

  • Study on the Effectiveness and Safety of MC2-25 Cream for Women with Vulvar Lichen Sclerosus

    Not recruiting

    2 1
    Investigated Diseases:
    • Lichen sclerosus
    Investigated Drugs:
    • Alanyl Glutamine
    Denmark

  • Study on Sodium Bicarbonate and Sodium Chloride for Patients with In-Hospital Cardiac Arrest

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Sodium Chloride
    • Sodium Hydrogen Carbonate
    Denmark
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!